Death Rates from Cancer in the US Continue to Drop

“The latest annual report from the American Cancer Society shows that death rates from cancer in the US are continuing to fall, ‘giving reasons to celebrate but not to stop,’ according to the voluntary health organization whose goal is the eradication of cancer.

“In figures to be published in CA: A Cancer Journal for Clinicians, the American Cancer Society (ACS) show how the death rate from cancer in the US has dropped by 22% since its peak in 1991.

“They say this means about 1.5 million deaths from cancer have been avoided in the last 20 years.

“The ACS estimate that in 2015, the US will see a total of 1,658,370 new cancer cases and 589,430 deaths due to the disease.

“Cancer was responsible for nearly 1 in 4 deaths in the US in 2011, making it the second leading cause of death overall -close behind heart disease.”


Cost of Prostate Cancer Surgery Varies Widely in the US

“The open market cost of a radical prostatectomy (RP) varies widely in U.S. hospitals, according to research published in the March issue of Urology.

“Scott C. Pate, M.D., of the University of Iowa in Iowa City, and colleagues conducted a telephone survey of a cohort of 100 U.S. hospitals to solicit price information for RP. The authors used a caller profile of an uninsured 55-year-old man recently diagnosed with Gleason 3 + 4 prostatic adenocarcinoma.”


Cancer Patients Face Treatment Disruptions Come June; Immediate and Severe Funding Cuts May Curtail Access to Cancer Clinical Trials

“The nation’s cancer clinical trial network, which provides care to thousands of patients across the United States, may have no choice but to abandon life-saving and life-extending research studies, including support for patients participating in those studies, due to crippling proposed budget cuts. For decades, federally-supported clinical trials have produced critical advances in the fight against cancer, representing one of the greatest returns on research investment anywhere. But this progress could soon grind to a halt due to far-reaching—and largely unnoticed—budgeting decisions that are happening in plain sight.”

Editor’s note: Clinical trials are not only important for testing the safety and effectiveness of new drugs; they also provide an avenue for patients who cannot benefit from standard treatment options to access new, cutting-edge treatments that could help them. In fact, our founder’s life was saved by his involvement in a clinical trial.


Cancer Patients Face Treatment Disruptions Come June; Immediate and Severe Funding Cuts May Curtail Access to Cancer Clinical Trials

“The nation’s cancer clinical trial network, which provides care to thousands of patients across the United States, may have no choice but to abandon life-saving and life-extending research studies, including support for patients participating in those studies, due to crippling proposed budget cuts. For decades, federally-supported clinical trials have produced critical advances in the fight against cancer, representing one of the greatest returns on research investment anywhere. But this progress could soon grind to a halt due to far-reaching—and largely unnoticed—budgeting decisions that are happening in plain sight.”

Editor’s note: Clinical trials are not only important for testing the safety and effectiveness of new drugs; they also provide an avenue for patients who cannot benefit from standard treatment options to access new, cutting-edge treatments that could help them. In fact, our founder’s life was saved by his involvement in a clinical trial.


Cancer Patients Face Treatment Disruptions Come June; Immediate and Severe Funding Cuts May Curtail Access to Cancer Clinical Trials

“The nation’s cancer clinical trial network, which provides care to thousands of patients across the United States, may have no choice but to abandon life-saving and life-extending research studies, including support for patients participating in those studies, due to crippling proposed budget cuts. For decades, federally-supported clinical trials have produced critical advances in the fight against cancer, representing one of the greatest returns on research investment anywhere. But this progress could soon grind to a halt due to far-reaching—and largely unnoticed—budgeting decisions that are happening in plain sight.”

Editor’s note: Clinical trials are not only important for testing the safety and effectiveness of new drugs; they also provide an avenue for patients who cannot benefit from standard treatment options to access new, cutting-edge treatments that could help them. In fact, our founder’s life was saved by his involvement in a clinical trial.

April 16, 2014 update: The NCI has released a letter to allay concerns about clinical trial funding come June. From the letter: “As in the past, full funding for all research activities required to carry out approved studies will be provided.” Read the full letter here.